Literature DB >> 31136432

CORR Insights®: Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.

Kyung-Hoi Koo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31136432      PMCID： PMC6554129          DOI： 10.1097/CORR.0000000000000749

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  16 in total

1.  Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.

Authors:  Dagmar Kubitza; Michael Becka; Wolfgang Mueck; Atef Halabi; Haidar Maatouk; Norbert Klause; Volkmar Lufft; Dominic D Wand; Thomas Philipp; Heike Bruck
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.

Authors:  David C Hoaglin; Neil Hawkins; Jeroen P Jansen; David A Scott; Robbin Itzler; Joseph C Cappelleri; Cornelis Boersma; David Thompson; Kay M Larholt; Mireya Diaz; Annabel Barrett
Journal:  Value Health       Date:  2011-06       Impact factor: 5.725

3.  Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty.

Authors:  Harman Chaudhry; Clary J Foote; Gordon Guyatt; Lehana Thabane; Toshi A Furukawa; Brad Petrisor; Mohit Bhandari
Journal:  Clin Orthop Relat Res       Date:  2015-04-14       Impact factor: 4.176

4.  Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility.

Authors:  Clary J Foote; Harman Chaudhry; Mohit Bhandari; Lehana Thabane; Toshi A Furukawa; Brad Petrisor; Gordon Guyatt
Journal:  Clin Orthop Relat Res       Date:  2015-04-14       Impact factor: 4.176

5.  Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty.

Authors:  Bun Jung Kang; Young-Kyun Lee; Hee Joong Kim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Clin Orthop Relat Res       Date:  2011-07-12       Impact factor: 4.176

6.  Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Authors:  Michael Rud Lassen; Alexander Gallus; Gary E Raskob; Graham Pineo; Dalei Chen; Luz Margarita Ramirez
Journal:  N Engl J Med       Date:  2010-12-23       Impact factor: 91.245

7.  Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.

Authors:  Bengt I Eriksson; Ola E Dahl; Michael H Huo; Andreas A Kurth; Stefan Hantel; Karin Hermansson; Janet M Schnee; Richard J Friedman
Journal:  Thromb Haemost       Date:  2011-01-12       Impact factor: 5.249

8.  Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.

Authors:  Bengt I Eriksson; Lars C Borris; Richard J Friedman; Sylvia Haas; Menno V Huisman; Ajay K Kakkar; Tiemo J Bandel; Horst Beckmann; Eva Muehlhofer; Frank Misselwitz; William Geerts
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

9.  Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study.

Authors:  Young-Hoo Kim; S H Oh; J S Kim
Journal:  J Bone Joint Surg Br       Date:  2003-07

10.  Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

Authors:  Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; Simon P Frostick; Martin H Prins; Rohan Hettiarachchi; Stefan Hantel; Janet Schnee; Harry R Büller
Journal:  Lancet       Date:  2007-09-15       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.